NO20092469L - Azasykloalkanderivater som inhibitorer av stearoyl-koenzym A-delta-9-desaturase - Google Patents
Azasykloalkanderivater som inhibitorer av stearoyl-koenzym A-delta-9-desaturaseInfo
- Publication number
- NO20092469L NO20092469L NO20092469A NO20092469A NO20092469L NO 20092469 L NO20092469 L NO 20092469L NO 20092469 A NO20092469 A NO 20092469A NO 20092469 A NO20092469 A NO 20092469A NO 20092469 L NO20092469 L NO 20092469L
- Authority
- NO
- Norway
- Prior art keywords
- desaturase
- delta
- coenzyme
- inhibitors
- azacycloalkane derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Emergency Medicine (AREA)
- Vascular Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Azasykloalkanderivater med Strukturformel I er selektive inhibitorer av stea- royl-koenzym A-delta-9-desaturase (SCD1) i forhold til andre kjente stearoyl-koenzym A-desaturaser. Forbindelsene ifølge den foreliggende oppfinnelse er anvendbare til forebyggelsen og behandlingen av tilstander relatert til unormal lipidsyntese og -metabolisme, inkludert hjerte- og karsykdom, slik som aterosklerose; overvekt; sukkersyke; nevrologisk sykdom; metabolsk syndrom; insulinresistens og leversteatose.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US87221606P | 2006-12-01 | 2006-12-01 | |
US89890007P | 2007-02-01 | 2007-02-01 | |
PCT/CA2007/002139 WO2008064474A1 (en) | 2006-12-01 | 2007-11-28 | Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20092469L true NO20092469L (no) | 2009-08-27 |
Family
ID=39467388
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20092469A NO20092469L (no) | 2006-12-01 | 2009-06-30 | Azasykloalkanderivater som inhibitorer av stearoyl-koenzym A-delta-9-desaturase |
Country Status (24)
Country | Link |
---|---|
US (1) | US8063224B2 (no) |
EP (1) | EP2099793B1 (no) |
JP (1) | JP5050061B2 (no) |
KR (1) | KR20090086623A (no) |
AR (1) | AR064026A1 (no) |
AT (1) | ATE543816T1 (no) |
AU (1) | AU2007327276B2 (no) |
BR (1) | BRPI0719702A2 (no) |
CA (1) | CA2670703C (no) |
CL (1) | CL2007003440A1 (no) |
CO (1) | CO6190521A2 (no) |
CR (1) | CR10858A (no) |
EA (1) | EA200970524A1 (no) |
EC (1) | ECSP099375A (no) |
GT (1) | GT200900144A (no) |
IL (1) | IL198824A0 (no) |
MA (1) | MA31017B1 (no) |
MX (1) | MX2009005713A (no) |
NO (1) | NO20092469L (no) |
PE (1) | PE20081199A1 (no) |
SV (1) | SV2009003275A (no) |
TN (1) | TN2009000212A1 (no) |
TW (1) | TW200826936A (no) |
WO (1) | WO2008064474A1 (no) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU4722801A (en) * | 2000-02-24 | 2001-09-03 | Xenon Genetics Inc | Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents |
CA2651700A1 (en) * | 2006-05-22 | 2007-11-29 | Merck Frosst Canada Ltd. | Cyclic amine derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
JP2009539884A (ja) * | 2006-06-12 | 2009-11-19 | メルク フロスト カナダ リミテツド | ステアロイル−コエンザイムaデルタ−9デサチュラーゼのインヒビターとしてのアゼチジン誘導体 |
JP2009539885A (ja) | 2006-06-13 | 2009-11-19 | メルク フロスト カナダ リミテツド | ステアロイルコエンザイムaデルタ−9デサチュラーゼの阻害剤としてのアザシクロペンタン誘導体 |
AU2007283401A1 (en) * | 2006-08-09 | 2008-02-14 | Merck Frosst Canada Ltd. | Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme A delta-9 desaturase |
AR064965A1 (es) | 2007-01-26 | 2009-05-06 | Merck Frosst Canada Inc | Derivados de azacicloalcanos como inhibidores de estearoil - coenzima a delta -9 desaturasa |
EP2148878A4 (en) * | 2007-04-20 | 2011-08-10 | Merck Canada Inc | NEW HETEROAROMATIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME-A-DELTA-9-DESATURASE |
CA2687338A1 (en) * | 2007-05-23 | 2008-11-27 | Merck Frosst Canada Ltd. | Bicyclic heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
WO2008157844A1 (en) | 2007-06-21 | 2008-12-24 | Forest Laboratories Holdings Limited | Novel piperazine derivatives as inhibitors of stearoyl-coa desaturase |
NZ583346A (en) * | 2007-07-19 | 2012-02-24 | Takeda Pharmaceutical | Solid preparation comprising alogliptin and metformin hydrochloride |
AU2008280784A1 (en) * | 2007-07-20 | 2009-01-29 | Merck Frosst Canada Ltd | Bicyclic heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
CA2735794A1 (en) * | 2008-09-08 | 2010-03-11 | Merck Frosst Canada Ltd. | Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
EP2398809B1 (en) * | 2009-02-17 | 2015-07-08 | Merck Canada Inc. | Novel spiro compounds useful as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
JP2012518603A (ja) * | 2009-02-23 | 2012-08-16 | メルク カナダ インコーポレイテッド | ステアロイル−コエンザイムaデルタ−9デサチュラーゼの阻害剤としての複素環誘導体 |
US20120010186A1 (en) * | 2009-03-23 | 2012-01-12 | Merck Frosst Canada Ltd. | Heterocyclic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
WO2011011872A1 (en) | 2009-07-28 | 2011-02-03 | Merck Frosst Canada Ltd. | Novel spiro compounds useful as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
JP5960683B2 (ja) | 2010-04-28 | 2016-08-02 | バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングBayer Intellectual Property GmbH | 殺真菌剤としてのケトヘテロアリールピペリジンおよび−ピペラジン誘導体 |
SG192176A1 (en) * | 2011-01-28 | 2013-08-30 | 4Sc Discovery Gmbh | Il17 and ifn-gamma inhibition for the treatment of autoimmune inflammation |
JP6254087B2 (ja) | 2011-10-15 | 2017-12-27 | ジェネンテック, インコーポレイテッド | 癌を治療するためのscd1アンタゴニスト |
WO2013062882A1 (en) * | 2011-10-26 | 2013-05-02 | Merck Canada Inc. | Scd inhibitors for the treatment of hcv |
US9233102B2 (en) | 2012-03-07 | 2016-01-12 | Mayo Foundation For Medical Education And Research | Methods and materials for treating cancer |
US9456998B2 (en) | 2012-05-22 | 2016-10-04 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Selective inhibitors of undifferentiated cells |
EP3529245A4 (en) * | 2016-10-24 | 2020-12-23 | Yumanity Therapeutics, Inc. | COMPOUNDS AND USES OF THE LATEST |
IL304017A (en) * | 2017-01-06 | 2023-08-01 | Yumanity Therapeutics Inc | Methods for treating neurological disorders |
CA3083000A1 (en) | 2017-10-24 | 2019-05-02 | Yumanity Therapeutics, Inc. | Compounds and uses thereof |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1595923A1 (de) * | 1965-02-20 | 1969-11-27 | Merck Ag E | 1-Aralkyl-4-(thiazolyl-2)-piperazine und Verfahren zu ihrer Herstellung |
WO1997026258A1 (en) | 1996-01-15 | 1997-07-24 | Janssen Pharmaceutica N.V. | Angiogenesis inhibiting pyridazinamines |
US20050119251A1 (en) | 2001-12-21 | 2005-06-02 | Jian-Min Fu | Nicotinamide derivatives and their use as therapeutic agents |
US7754711B2 (en) | 2003-07-30 | 2010-07-13 | Xenon Pharmaceuticals Inc. | Pyridazine derivatives and their use as therapeutic agents |
US7514436B2 (en) | 2003-07-30 | 2009-04-07 | Xenon Pharmaceuticals Inc. | Pyridazine derivatives and their use as therapeutic agents |
US7345043B2 (en) | 2004-04-01 | 2008-03-18 | Miikana Therapeutics | Inhibitors of histone deacetylase |
AU2005329423A1 (en) | 2004-09-20 | 2006-09-28 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors |
EP1799668A1 (en) | 2004-09-20 | 2007-06-27 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as mediators of stearoyl-coa desaturase |
AR051092A1 (es) * | 2004-09-20 | 2006-12-20 | Xenon Pharmaceuticals Inc | Derivados heterociclicos y su uso como inhibidores de la estearoil-coa |
BRPI0515500A (pt) | 2004-09-20 | 2008-07-29 | Xenon Pharmaceuticals Inc | derivados piridazina para inibição de estearoil-coa-desaturase |
CA2580781A1 (en) | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Bicyclic heterocyclic derivatives and their use as inhibitors of stearoyl-coa-desaturase (scd) |
JP5043668B2 (ja) | 2004-09-20 | 2012-10-10 | ゼノン・ファーマシューティカルズ・インコーポレイテッド | 複素環誘導体および治療薬としてのそれらの使用 |
US7919496B2 (en) * | 2004-09-20 | 2011-04-05 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-CoA desaturase enzymes |
BRPI0515489A (pt) | 2004-09-20 | 2008-07-29 | Xenon Pharmaceuticals Inc | derivados heterocìclicos e sua utilização como inibidores de estearoil-coa desaturase |
GT200600046A (es) | 2005-02-09 | 2006-09-25 | Terapia de combinacion | |
WO2006125181A2 (en) | 2005-05-19 | 2006-11-23 | Xenon Pharmaceuticals Inc. | Piperidine derivatives and their use as stearoyl-coa desaturase modulators |
JP2008545760A (ja) | 2005-06-09 | 2008-12-18 | メルク フロスト カナダ リミテツド | ステアロイル−コエンザイムaデルタ−9デサチュラーゼのインヒビターとしてのアザシクロヘキサン誘導体 |
JP2009501733A (ja) | 2005-07-20 | 2009-01-22 | メルク フロスト カナダ リミテツド | ステアロイルコエンザイムaデルタ−9デサチュラーゼの阻害剤としてのヘテロ芳香族化合物 |
EP1934205A4 (en) | 2005-10-05 | 2010-06-02 | Merck Frosst Canada Ltd | SUBSTITUTED QUINOLINES AS INHIBITORS OF LEUCOTRIENE BIOSYNTHESIS |
EP1951731A4 (en) | 2005-11-15 | 2010-07-07 | Merck Frosst Canada Ltd | AZACYCLOHEXANE DERIVATIVES AS DELTA-9 DEATURASE STÉAROYL-COENZYME INHIBITORS |
WO2007071023A1 (en) | 2005-12-20 | 2007-06-28 | Merck Frosst Canada Ltd. | Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
CA2651700A1 (en) | 2006-05-22 | 2007-11-29 | Merck Frosst Canada Ltd. | Cyclic amine derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
JP2009539884A (ja) | 2006-06-12 | 2009-11-19 | メルク フロスト カナダ リミテツド | ステアロイル−コエンザイムaデルタ−9デサチュラーゼのインヒビターとしてのアゼチジン誘導体 |
JP2009539885A (ja) | 2006-06-13 | 2009-11-19 | メルク フロスト カナダ リミテツド | ステアロイルコエンザイムaデルタ−9デサチュラーゼの阻害剤としてのアザシクロペンタン誘導体 |
AU2007283401A1 (en) | 2006-08-09 | 2008-02-14 | Merck Frosst Canada Ltd. | Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme A delta-9 desaturase |
AU2007312866A1 (en) | 2006-10-20 | 2008-04-24 | Merck Frosst Canada Ltd. | Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme A delta-9 desaturase |
AR064965A1 (es) | 2007-01-26 | 2009-05-06 | Merck Frosst Canada Inc | Derivados de azacicloalcanos como inhibidores de estearoil - coenzima a delta -9 desaturasa |
-
2007
- 2007-11-26 TW TW096144835A patent/TW200826936A/zh unknown
- 2007-11-28 AT AT07845603T patent/ATE543816T1/de active
- 2007-11-28 JP JP2009538560A patent/JP5050061B2/ja not_active Expired - Fee Related
- 2007-11-28 MX MX2009005713A patent/MX2009005713A/es unknown
- 2007-11-28 EA EA200970524A patent/EA200970524A1/ru unknown
- 2007-11-28 KR KR1020097013826A patent/KR20090086623A/ko not_active Application Discontinuation
- 2007-11-28 CA CA2670703A patent/CA2670703C/en not_active Expired - Fee Related
- 2007-11-28 AU AU2007327276A patent/AU2007327276B2/en not_active Ceased
- 2007-11-28 BR BRPI0719702-0A patent/BRPI0719702A2/pt not_active IP Right Cessation
- 2007-11-28 WO PCT/CA2007/002139 patent/WO2008064474A1/en active Application Filing
- 2007-11-28 EP EP07845603A patent/EP2099793B1/en active Active
- 2007-11-29 AR ARP070105302A patent/AR064026A1/es not_active Application Discontinuation
- 2007-11-29 CL CL200703440A patent/CL2007003440A1/es unknown
- 2007-11-30 PE PE2007001699A patent/PE20081199A1/es not_active Application Discontinuation
- 2007-11-30 US US11/998,501 patent/US8063224B2/en active Active
-
2009
- 2009-05-19 IL IL198824A patent/IL198824A0/en unknown
- 2009-05-27 SV SV2009003275A patent/SV2009003275A/es unknown
- 2009-05-27 GT GT200900144A patent/GT200900144A/es unknown
- 2009-05-28 CO CO09054946A patent/CO6190521A2/es not_active Application Discontinuation
- 2009-05-29 TN TNP2009000212A patent/TN2009000212A1/fr unknown
- 2009-06-01 EC EC2009009375A patent/ECSP099375A/es unknown
- 2009-06-10 CR CR10858A patent/CR10858A/es unknown
- 2009-06-22 MA MA32023A patent/MA31017B1/fr unknown
- 2009-06-30 NO NO20092469A patent/NO20092469L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
PE20081199A1 (es) | 2008-10-19 |
AU2007327276A1 (en) | 2008-06-05 |
TW200826936A (en) | 2008-07-01 |
SV2009003275A (es) | 2009-11-18 |
WO2008064474A1 (en) | 2008-06-05 |
CO6190521A2 (es) | 2010-08-19 |
MA31017B1 (fr) | 2009-12-01 |
MX2009005713A (es) | 2009-06-08 |
EA200970524A1 (ru) | 2009-12-30 |
ECSP099375A (es) | 2009-07-31 |
JP5050061B2 (ja) | 2012-10-17 |
CA2670703C (en) | 2012-05-15 |
EP2099793A1 (en) | 2009-09-16 |
EP2099793B1 (en) | 2012-02-01 |
GT200900144A (es) | 2011-06-23 |
AU2007327276B2 (en) | 2011-06-09 |
TN2009000212A1 (en) | 2010-10-18 |
CA2670703A1 (en) | 2008-06-05 |
US8063224B2 (en) | 2011-11-22 |
KR20090086623A (ko) | 2009-08-13 |
AR064026A1 (es) | 2009-03-04 |
BRPI0719702A2 (pt) | 2013-12-17 |
CL2007003440A1 (es) | 2008-04-04 |
JP2010510993A (ja) | 2010-04-08 |
ATE543816T1 (de) | 2012-02-15 |
US20080132542A1 (en) | 2008-06-05 |
CR10858A (es) | 2009-06-25 |
EP2099793A4 (en) | 2010-12-29 |
IL198824A0 (en) | 2010-02-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20092469L (no) | Azasykloalkanderivater som inhibitorer av stearoyl-koenzym A-delta-9-desaturase | |
NO20073806L (no) | Substituerte pyridinyl og pyrimidinylderivater som modulatorer av metabolisme og behandling av lidelser relatert til dette | |
BR112012021771A2 (pt) | métodos de uso de inibidores de contransportadores de sódio-glicose 1 e 2. | |
MX2008013484A (es) | Derivados de lactamas de ciclohexilpirazol como inhibidores de 11-beta-hidroxiesteroide deshidrogenasa 1. | |
EA200870474A1 (ru) | Ингибиторы 11-бета-гидроксистероид дегидрогеназы 1 | |
IL213425A0 (en) | Adamantyl derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase | |
NO20084278L (no) | Bezothiazol derivatives as beta2 adrenoreceptor agonists | |
EA200970090A1 (ru) | Модуляторы метаболизма и лечение связанных с ним расстройств | |
NO20065868L (no) | Substituerte aryl- og heteroarylderivater som metabolisme- og profylkasemodulatorer og behandling av forstyrrelser forbundet med dette | |
UA98651C2 (ru) | Спироциклы как ингибиторы 11-бета гидроксилстероиддегидрогеназы типа 1 | |
MA30686B1 (fr) | Inhibiteurs de la 11-beta-hydroxysteroide deshydrogenase. | |
MX2010001754A (es) | Derivados de azepina como inhibidores de gamma secretasa. | |
ATE471311T1 (de) | Inhibitoren von11-beta- hydroxysteroiddehydrogenase 1 | |
UA97257C2 (en) | Indole derivatives | |
GEP20135724B (en) | Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for treatment or prevention of diabetes | |
PE20091425A1 (es) | Derivados de aminotiazol | |
MX2009010894A (es) | Derivados de 3-hidroquinazolin-4-ona para utilizarse como inhibidores de estearoil-coa-desaturasa. | |
EA201300759A1 (ru) | Новые производные nip тиазола в качестве ингибиторов 11-бета-гидроксистероид дегидрогеназы-1 | |
CY1113645T1 (el) | Παραγωγα 7-αζαϊνδολης ως επιλεκτικοι αναστολεις 11-βητα-υδροξυστεροειδους δεϋδρογενασης τυπου 1 | |
EA200970170A1 (ru) | Производные 4-триметиламмоний-3-аминобутирата и 4-триметилфосфоний-3-аминобутирата как ингибиторы срт | |
GEP20135804B (en) | Glucocorticoid receptor agonist comprising novel 1,2,3,4-tetrahydroquinoxaline derivative containing phenyl group having sulfonic acid ester introduced therein as substituent | |
NO20092719L (no) | Nye kromen-2-on-derivater og deres anvendelse som monoaminneurotransmitter-gjenopptaksinhibitorer | |
GEP20094745B (en) | Novel naphthalenic derivatives, method for the preparation thereof, and pharmaceutical compositions containing same | |
EA201100419A1 (ru) | Сопряженные пирролидино-циклопропановые производные в качестве селективных ингибиторов 11-бета-гидроксистероид дегидрогеназы 1 типа | |
TN2011000294A1 (en) | Arylcyclopropylacetamide derivatives useful as glucokinase activators |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RE | Reestablishment of rights (par. 72 patents act) | ||
FC2A | Withdrawal, rejection or dismissal of laid open patent application | ||
FC2A | Withdrawal, rejection or dismissal of laid open patent application |